Inhibition of NF-kappaB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia. - Wikidata - awgldk - TriplyDB

Inhibition of NF-kappaB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia.

Inhibition of NF-kappaB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia.

http://www.wikidata.org/entity/Q34898661

about

Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models Blockade of TRPM7 channel activity and cell death by inhibitors of 5-lipoxygenase.Injury-related production of cysteinyl leukotrienes contributes to brain damage following experimental traumatic brain injury.Effect of leukotriene inhibitors on evolution of experimental brain contusions.5-Lypoxygenase products are involved in renal tubulointerstitial injury induced by albumin overload in proximal tubules in mice.Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats.S-nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats.The protective effect of caffeic acid on global cerebral ischemia-reperfusion injury in rats.Promoting endothelial function by S-nitrosoglutathione through the HIF-1α/VEGF pathway stimulates neurorepair and functional recovery following experimental stroke in rats.Blocking a vicious cycle nNOS/peroxynitrite/AMPK by S-nitrosoglutathione: implication for stroke therapy.Plasticity of cytochrome P450 isozyme expression in rat trigeminal ganglia neurons during inflammation.Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer.The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke Neuroprotective effect of Pycnogenol® following traumatic brain injury.Disruption of the alox5ap gene ameliorates focal ischemic stroke: possible consequence of impaired leukotriene biosynthesis.Inhibition of lipoxygenases and cyclooxygenases by linoleyl hydroxamic acid: comparative in vitro studies.Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease.It's all in the family: multiple Toll-like receptors offer promise as novel therapeutic targets for stroke neuroprotection.Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat.Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact.Recent developments in the inhibitors of neuroinflammation and neurodegeneration: inflammatory oxidative enzymes as a drug target.TRPM7 in cerebral ischemia and potential target for drug development in stroke.The genetics of vascular incidents associated with second-generation antipsychotic administration.Small molecule inhibitors in the treatment of cerebral ischemia.A COX/5-LOX Inhibitor Licofelone Revealed Anticonvulsant Properties Through iNOS Diminution in Mice.Suppression of LPS-induced inflammatory responses by inflexanin B in BV2 microglial cells.Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages.Inhibition of leukotriene receptors boosts neural progenitor proliferation.5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9.Inhibition of 5-lipoxygenase attenuates inflammation and BONE resorption in lipopolysaccharide-induced periodontal disease.5-Lipoxygenase inhibitor zileuton inhibits neuronal apoptosis following focal cerebral ischemia.

P2860

Q30499792-EB988999-1BEF-4C81-9D60-620C0F63D4DF Q33612288-3832C948-F203-4954-A081-13DA38AC9ED0 Q33657698-7EE33DB1-47F9-41F3-862C-59970AE56A8F Q33990806-DF2A8648-379B-4E33-AE8A-58D0309D6FFB Q34323094-59C1CD74-8990-443F-B80C-A8881F303529 Q34579572-D5FEBAD3-6D78-457C-8B2E-39C348273AC0 Q35172025-865CA154-59BE-47AB-8BA1-C9A1CD52855F Q35532034-CFBEC367-8489-48B6-A81F-0A03F7E1C7B8 Q35535466-CBF7A878-A8F1-4623-B0CC-BC925AE5BC78 Q35691264-680CA6FC-52A0-4578-82AE-A675A41ADC7A Q36199024-70B84E2D-F092-4FDD-A159-D0E32E7A126B Q36230542-28EB1248-D377-4E0E-BC16-2A7E736C720E Q36347434-4F3C2F32-AC4C-4A30-B6FB-7A0FD490E29A Q36500616-7BEF2618-C064-42FE-BE44-715042BD42A5 Q36568292-D677CB24-C9C3-4F91-8DB3-5B1DDEB9DAA8 Q36662661-50BD1173-4AC1-4F0F-9751-C3194B5CFB13 Q36974939-C3E3A4C1-4468-473D-B9FE-ADF7B3A33A91 Q37259848-7526A4E1-9B95-4547-A5B7-0E4A3CE1BCB6 Q37336053-177239D3-748F-46C2-B388-444E80100A30 Q37420533-3AF4043B-D9A5-43FE-A06D-33C4B6BC47A8 Q37799603-01441C43-E4D4-4133-9176-7357DD472D61 Q37873298-94E8D961-5C3F-47A1-9E15-766EB5C771D0 Q38170191-DAA55CDE-9682-4737-9D09-30D0A5C69564 Q38184644-2AB935CE-B647-473C-85C4-F11EF5CCE27C Q38980572-49E78ACB-BCD5-4E9F-B856-604C2A9CFE8A Q39185717-D35EDB0F-689B-490F-A80E-58B248F3A15C Q39572651-CB298217-5601-4CA8-A254-7E1BD34A8C46 Q39674665-A74F54FC-8830-4C32-A15B-4D1644590BC6 Q46077175-CA211BD0-6333-400C-AB6F-F9F6BC8FC75B Q49581674-8E779E2E-A2E1-4ABE-BE48-05ADC895EC9F Q50973523-1953F7FF-7BA9-4514-83A5-D76F1875D278

P2860

Inhibition of NF-kappaB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia.

http://www.wikidata.org/entity/Q34898661

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Inhibition of NF-kappaB activa ...... el of focal cerebral ischemia.

@ast

Inhibition of NF-kappaB activa ...... el of focal cerebral ischemia.

@en

Inhibition of NF-kappaB activa ...... el of focal cerebral ischemia.

@nl

type

label

Inhibition of NF-kappaB activa ...... el of focal cerebral ischemia.

@ast

Inhibition of NF-kappaB activa ...... el of focal cerebral ischemia.

@en

Inhibition of NF-kappaB activa ...... el of focal cerebral ischemia.

@nl

prefLabel

Inhibition of NF-kappaB activa ...... el of focal cerebral ischemia.

@ast

Inhibition of NF-kappaB activa ...... el of focal cerebral ischemia.

@en

Inhibition of NF-kappaB activa ...... el of focal cerebral ischemia.

@nl

P1433

Q34898661-83F99227-4122-4EFA-8267-6E04F443DA93

P1476

Q34898661-8274701E-2A90-4170-8682-626278903907

P2093

Q34898661-A1FA0AC7-2B59-4100-B249-D227E2726A9C

Q34898661-A5AFA4F8-5E68-42B3-B733-76E19A3AFC1B

Q34898661-BE25F40D-083D-49D1-A923-73964E7F13C7

Q34898661-C954C12C-A79F-4306-93A9-216C24901576

Q34898661-CE503083-4E19-4B1E-B3E4-6DA3E2DCB860

Q34898661-EB0E53CA-1B74-4647-8897-9F0F9D61D15A

Q34898661-ECF5CA62-EA43-451E-9284-9F22C8F38E6C

P2860

Q34898661-0498EB09-8F59-4FB1-B17C-F53674A2CD0B

Q34898661-1180753A-E3B7-4D27-8A57-10CCC3745905

Q34898661-135F7F12-2A1B-45EF-A782-96355F5A1F87

Q34898661-17212CF6-934B-4DBA-9A0F-B6395BAB785E

Q34898661-1A0EFCDE-9789-485E-8430-EA7D034553AC

Q34898661-1D7401C8-F13C-41CE-B1C2-5C16385CCC04

Q34898661-1F50FEA3-D255-48D2-8D9B-215882E7FE18

Q34898661-227894B7-2B53-4212-BEDC-D4355A138649

Q34898661-2CF52D3F-3965-4CF3-9B2B-E751D764513A

Q34898661-2ED85722-113C-4012-B4DA-3494132149CC

P2888

Q34898661-CAB2DEAF-B8D1-4519-8450-79C5006E6C38

P304

Q34898661-4BFC44CA-8793-44D6-BB46-CA022A301261

P31

Q34898661-D908D43A-CDE9-4883-B879-9E450B2CFDE3

P356

Q34898661-9DB679F7-2CC8-4CC6-B4A0-438E9A8D08E7

P478

Q34898661-91B6F08C-DE6A-4947-BB3B-69A61B381649

P577

Q34898661-485534DF-E789-4160-9FBE-05C90E2088AE

P5875

Q34898661-FFA4083A-2E2D-4C7F-A8F1-5380C1772AC9

P6179

Q34898661-AEF63C37-D788-487B-9D6F-0DBE88B1BF21

P698

Q34898661-8B147714-CF18-414D-A482-0FF6E858BFDA

P921

Q34898661-002F36CD-A745-4056-95AD-0A0AA386C9B8

Q34898661-60C02785-FF90-45F9-B327-E3A3A69A076A

Q34898661-DB8B83AE-907E-4964-99D9-F276E9965693

P932

Q34898661-7176763E-6649-426F-B94F-06F81CC2DD27

P356

P1433

Journal of Neuroinflammation

P1476

Inhibition of NF-kappaB activa ...... el of focal cerebral ischemia.

@en

P2093

Avtar K Singh

http://www.w3.org/2001/XMLSchema#string

Chinnasamy Elango

http://www.w3.org/2001/XMLSchema#string

Inderjit Singh

http://www.w3.org/2001/XMLSchema#string

Manu Jatana

http://www.w3.org/2001/XMLSchema#string

Mubeen A Ansari

http://www.w3.org/2001/XMLSchema#string

Mushfiquddin Khan

http://www.w3.org/2001/XMLSchema#string

Shailendra Giri

http://www.w3.org/2001/XMLSchema#string

P2860

The organization and consequences of eicosanoid signaling

Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

Pathobiology of ischaemic stroke: an integrated view

Glutathione adducts of oxyeicosanoids

Reversible middle cerebral artery occlusion without craniectomy in rats

New role for epoxyeicosatrienoic acids as anti-inflammatory mediators

Rho A negatively regulates cytokine-mediated inducible nitric oxide synthase expression in brain-derived transformed cell lines: negative regulation of IKKalpha

Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies.

Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate.

P2888

P304

12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-2094-3-12

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7091333

http://www.w3.org/2001/XMLSchema#string

P6179

1015747724

http://www.w3.org/2001/XMLSchema#string

P698

16689995

http://www.w3.org/2001/XMLSchema#string

P921

cerebral infarction

P932

1526713

http://www.w3.org/2001/XMLSchema#string